$TLYS
TILLY'S, INC.

2021 Q2 Form 10-Q Financial Statement

#000162828021011826 Filed on June 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $163.2M $77.29M
YoY Change 111.1% -40.69%
Cost Of Revenue $108.3M $75.70M
YoY Change 43.1% -20.0%
Gross Profit $54.84M $1.594M
YoY Change 3340.34% -95.53%
Gross Profit Margin 33.61% 2.06%
Selling, General & Admin $39.97M $30.00M
YoY Change 33.24% -15.6%
% of Gross Profit 72.88% 1881.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.324M $5.020M
YoY Change -13.86% -3.65%
% of Gross Profit 7.88% 314.93%
Operating Expenses $39.97M $30.00M
YoY Change 33.24% -15.6%
Operating Profit $14.87M -$28.40M
YoY Change -152.37% -19552.74%
Interest Expense $29.00K $300.0K
YoY Change -90.33%
% of Operating Profit 0.19%
Other Income/Expense, Net -$115.0K $409.0K
YoY Change -128.12% -50.66%
Pretax Income $14.76M -$27.99M
YoY Change -152.73% -2970.97%
Income Tax $3.800M -$10.60M
% Of Pretax Income 25.75%
Net Earnings $10.96M -$17.40M
YoY Change -163.0% -2669.42%
Net Earnings / Revenue 6.72% -22.51%
Basic Earnings Per Share -$0.59
Diluted Earnings Per Share $359.0K -$0.59
COMMON SHARES
Basic Shares Outstanding 29.88M shares 29.68M shares
Diluted Shares Outstanding 30.53M shares 29.68M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $157.6M $110.8M
YoY Change 42.2% 1.13%
Cash & Equivalents $81.02M $65.13M
Short-Term Investments $76.60M $45.71M
Other Short-Term Assets $4.591M $2.100M
YoY Change 118.62% -60.38%
Inventory $65.34M $67.65M
Prepaid Expenses
Receivables $9.701M $13.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $237.3M $194.3M
YoY Change 22.14% 7.72%
LONG-TERM ASSETS
Property, Plant & Equipment $54.14M $61.94M
YoY Change -12.6% -12.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.231M $7.422M
YoY Change -83.41% 241.08%
Total Long-Term Assets $289.2M $321.9M
YoY Change -10.15% 1.58%
TOTAL ASSETS
Total Short-Term Assets $237.3M $194.3M
Total Long-Term Assets $289.2M $321.9M
Total Assets $526.5M $516.2M
YoY Change 2.0% 3.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.86M $24.84M
YoY Change 44.38% 5.78%
Accrued Expenses $29.11M $13.59M
YoY Change 114.19% -20.26%
Deferred Revenue $2.600M
YoY Change 52.94%
Short-Term Debt $0.00 $23.70M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $146.8M $143.5M
YoY Change 2.27% 31.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.528M $558.0K
YoY Change 173.84% -60.76%
Total Long-Term Liabilities $205.2M $558.0K
YoY Change 36666.13% -60.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.8M $143.5M
Total Long-Term Liabilities $205.2M $558.0K
Total Liabilities $351.9M $373.2M
YoY Change -5.7% 12.15%
SHAREHOLDERS EQUITY
Retained Earnings $16.09M -$11.12M
YoY Change -244.8% -179.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $174.6M $143.0M
YoY Change
Total Liabilities & Shareholders Equity $526.5M $516.2M
YoY Change 2.0% 3.8%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $10.96M -$17.40M
YoY Change -163.0% -2669.42%
Depreciation, Depletion And Amortization $4.324M $5.020M
YoY Change -13.86% -3.65%
Cash From Operating Activities $19.28M -$19.57M
YoY Change -198.52% 758.91%
INVESTING ACTIVITIES
Capital Expenditures $5.492M $3.548M
YoY Change 54.79% 15.99%
Acquisitions
YoY Change
Other Investing Activities -$11.61M $24.11M
YoY Change -148.13% 5506.98%
Cash From Investing Activities -$17.10M $20.56M
YoY Change -183.14% -881.6%
FINANCING ACTIVITIES
Cash Dividend Paid $1.00 $29.68M
YoY Change -100.0% 0.76%
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.651M -$6.002M
YoY Change -144.17% -79.58%
NET CHANGE
Cash From Operating Activities $19.28M -$19.57M
Cash From Investing Activities -$17.10M $20.56M
Cash From Financing Activities $2.651M -$6.002M
Net Change In Cash $4.831M -$5.004M
YoY Change -196.54% -85.41%
FREE CASH FLOW
Cash From Operating Activities $19.28M -$19.57M
Capital Expenditures $5.492M $3.548M
Free Cash Flow $13.79M -$23.11M
YoY Change -159.64% 333.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30682000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13591000 USD
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001524025
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-29
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-05-01
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-35535
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
TILLY’S, INC.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2164791
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
10 Whatney
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
CY2021Q2 dei City Area Code
CityAreaCode
949
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
609-5599
CY2021Q2 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
CY2021Q2 dei Trading Symbol
TradingSymbol
TLYS
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81015000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76184000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65133000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
76633000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
64955000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
45981000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9701000 USD
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8724000 USD
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
13421000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
65341000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
55698000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
67650000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4956000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6595000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2092000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
237646000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
212156000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
194277000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
219918000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
227881000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
252554000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54139000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52639000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61941000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12530000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12797000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7422000 USD
CY2021Q2 us-gaap Assets
Assets
524233000 USD
CY2021Q1 us-gaap Assets
Assets
505473000 USD
CY2020Q2 us-gaap Assets
Assets
516194000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
35860000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24983000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24837000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29110000 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
23675000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
12913000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13492000 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10719000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14489000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9899000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5098000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53633000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54503000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65595000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
146005000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
143515000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
133559000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
203627000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211292000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229127000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
349632000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
344851000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
373200000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158454000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155437000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153878000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11115000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16094000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5135000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
23000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
201000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
174601000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
142994000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
524233000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
505473000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516194000 USD
CY2021Q2 us-gaap Revenues
Revenues
163157000 USD
CY2020Q2 us-gaap Revenues
Revenues
77289000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108318000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
75695000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
54839000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1594000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39965000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29995000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3800000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14874000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28401000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-115000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
409000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14759000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27992000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10597000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29878000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29677000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30529000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29677000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-13000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10962000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17408000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
366000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2651000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
174601000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
501000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-13000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
142994000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4324000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5024000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
333000 USD
CY2021Q2 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
117000 USD
CY2020Q2 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
0 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
366000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
501000 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-62000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
29000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
330000 USD
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-285000 USD
CY2021Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-591000 USD
CY2021Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-250000 USD
CY2020Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23675000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1615000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2411000 USD
CY2020Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5936000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9760000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10749000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10617000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4661000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1745000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5284000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-579000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1042000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4590000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2092000 USD
CY2021Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1795000 USD
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2020Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
9741000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19277000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19566000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5492000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3548000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2021Q2 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
29000 USD
CY2020Q2 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2021Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36644000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2020Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5996000 USD
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25000000 USD
CY2020Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30108000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17097000 USD
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
29677000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2651000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20564000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2651000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6002000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3683000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4831000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5004000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76184000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70137000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81015000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65133000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
67000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-42000 USD
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2936000 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2066000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4621 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1896 USD
CY2021Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2021 refer to the fiscal year ending January 29,<br/>2022. References to the fiscal quarter or first three months ended May 1, 2021 and May 2, 2020 refer to the thirteen week periods ended as of those dates, respectively.</span></div>
CY2021Q2 us-gaap Number Of Stores
NumberOfStores
238 store
CY2021Q2 tlys Number Of States
NumberOfStates
33 State
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
3900000 USD
CY2021Q2 us-gaap Revenues
Revenues
163157000 USD
CY2020Q2 us-gaap Revenues
Revenues
77289000 USD
CY2021Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2200000 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1400000 USD
CY2020Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1700000 USD
CY2021Q2 tlys Unredeemed Awardsand Accumulated Points Expiration Period
UnredeemedAwardsandAccumulatedPointsExpirationPeriod
P365D
CY2021Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2100000 USD
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
4500000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
3900000 USD
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
2600000 USD
CY2020Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
900000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
51296000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
257260000 USD
CY2021Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3888000 USD
CY2021Q2 tlys Number Of Stores Covid Lease Not Yet Negotiated
NumberOfStoresCOVIDLeaseNotYetNegotiated
10
CY2021Q2 tlys Operating Lease Withheld Lease Payments
OperatingLeaseWithheldLeasePayments
800000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3841000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
52171000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
64075000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
19515000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
19756000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
17168000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
53279000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
42451000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
33268000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
63312000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
308556000 USD
CY2021Q2 tlys Lessee Operating Lease Lease Not Yet Commenced Value
LesseeOperatingLeaseLeaseNotYetCommencedValue
1200000 USD
CY2021Q2 tlys Lessee Operating Lease Subsequent Modification
LesseeOperatingLeaseSubsequentModification
3800000 USD
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15627000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15915000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
5615000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0649
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0401
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
651000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3800000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.257
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10600000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30529000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29677000 shares
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.379
CY2021Q2 us-gaap Marketable Securities
MarketableSecurities
76602000 USD
CY2021Q2 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
32000 USD
CY2021Q2 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
1000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
76633000 USD
CY2021Q1 us-gaap Marketable Securities
MarketableSecurities
64928000 USD
CY2021Q1 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
28000 USD
CY2021Q1 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
1000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
64955000 USD
CY2020Q2 us-gaap Marketable Securities
MarketableSecurities
45706000 USD
CY2020Q2 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
275000 USD
CY2020Q2 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
0 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
45981000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
48500000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
23700000 USD
CY2021Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
536000 USD
CY2020Q2 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
203000 USD
CY2021Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
9 store
CY2020Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
12 store
CY2021Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
CY2020Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
5 store
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2602212 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.19
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
503700 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.74
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
359907 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.37
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
246718 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.33
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
32000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.26
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2467287 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.61
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9019000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1272206 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.00
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4453000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.64
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.05
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M24D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.599
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.573
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10959000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
366000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
501000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5100000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29878000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29677000 shares

Files In Submission

Name View Source Status
0001628280-21-011826-index-headers.html Edgar Link pending
0001628280-21-011826-index.html Edgar Link pending
0001628280-21-011826.txt Edgar Link pending
0001628280-21-011826-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
promotionletter-bobbygoodw.htm Edgar Link pending
q12021ex311.htm Edgar Link pending
q12021ex312.htm Edgar Link pending
q12021ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20210501.htm Edgar Link pending
tlys-20210501.xsd Edgar Link pending
tlys-20210501_cal.xml Edgar Link unprocessable
tlys-20210501_def.xml Edgar Link unprocessable
tlys-20210501_htm.xml Edgar Link completed
tlys-20210501_lab.xml Edgar Link unprocessable
tlys-20210501_pre.xml Edgar Link unprocessable